About Anaconda Biomed
Anaconda Biomed is a company based in Barcelona (Spain) founded in 2015 by Ofir Arad and Marc Ribo.. Anaconda Biomed has raised $38.96 million across 3 funding rounds from investors including EIT Health, Asabys Partners and Ysios Capital. Anaconda Biomed offers products and services including ANA SYSTEM and ANA 5. Anaconda Biomed operates in a competitive market with competitors including Rapid Medical, Fluid Biomed, Cerus Endovascular, Oxford Endovascular and MicroVention, among others.
- Headquarter Barcelona, Spain
- Founders Ofir Arad, Marc Ribo
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Anaconda Biomed S.L.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$38.96 M (USD)
in 3 rounds
-
Latest Funding Round
$22.16 M (USD), Series B
Dec 04, 2019
-
Investors
EIT Health
& 5 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Anaconda Biomed
Anaconda Biomed offers a comprehensive portfolio of products and services, including ANA SYSTEM and ANA 5. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Catheter system for restoring blood flow in ischemic strokes via suction.
Advanced catheter for safe mechanical thrombectomy procedures in vessels.
Unlock access to complete
Unlock access to complete
Funding Insights of Anaconda Biomed
Anaconda Biomed has successfully raised a total of $38.96M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $22.16 million completed in December 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series B — $22.2M
-
First Round
First Round
(22 May 2017)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2019 | Amount | Series B - Anaconda Biomed | Valuation | Asabys Partners | |
| Aug, 2018 | Amount | Grant - Anaconda Biomed | Valuation |
investors |
|
| May, 2017 | Amount | Series A - Anaconda Biomed | Valuation | Ysios Capital , Innogest Capital |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Anaconda Biomed
Anaconda Biomed has secured backing from 6 investors, including venture fund investors. Prominent investors backing the company include EIT Health, Asabys Partners and Ysios Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Ysios Capital is recognized as a leading life sciences investor.
|
Founded Year | Domain | Location | |
|
VC firm investing in seed and early stage companies in Italy
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Anaconda Biomed
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Anaconda Biomed
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Anaconda Biomed Comparisons
Competitors of Anaconda Biomed
Anaconda Biomed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Rapid Medical, Fluid Biomed, Cerus Endovascular, Oxford Endovascular and MicroVention, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Neurovascular interventional devices including distal access catheters are developed.
|
|
| domain | founded_year | HQ Location |
A hybrid polymer-metal stent for brain aneurysms is developed.
|
|
| domain | founded_year | HQ Location |
Interventional neuroradiology devices are developed for minimally invasive aneurysm treatment.
|
|
| domain | founded_year | HQ Location |
Metallic mesh devices for brain aneurysms are developed.
|
|
| domain | founded_year | HQ Location |
Neuroendovascular technologies for cerebral and peripheral vascular diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Anaconda Biomed
Frequently Asked Questions about Anaconda Biomed
When was Anaconda Biomed founded?
Anaconda Biomed was founded in 2015 and raised its 1st funding round 2 years after it was founded.
Where is Anaconda Biomed located?
Anaconda Biomed is headquartered in Barcelona, Spain. It is registered at Barcelona, Catalonia, Spain.
Who is the current CEO of Anaconda Biomed?
Trent Reutiman is the current CEO of Anaconda Biomed.
Is Anaconda Biomed a funded company?
Anaconda Biomed is a funded company, having raised a total of $38.96M across 3 funding rounds to date. The company's 1st funding round was a Series A of $16.8M, raised on May 22, 2017.
What does Anaconda Biomed do?
Anaconda Biomed was founded in 2015 in Barcelona, Spain, operating in the medical devices sector. Catheters for blood clot removal in mechanical thromboectomy procedures are developed by the company. The ANA Advanced Neurovascular Access system is featured, including the ANA5 Funnel Catheter, which combines aspiration with flow restriction. Focus is maintained on neurovascular applications across European operations.
Who are the top competitors of Anaconda Biomed?
Anaconda Biomed's top competitors include Rapid Medical, Fluid Biomed and MicroVention.
What products or services does Anaconda Biomed offer?
Anaconda Biomed offers ANA SYSTEM and ANA 5.
Who are Anaconda Biomed's investors?
Anaconda Biomed has 6 investors. Key investors include EIT Health, Asabys Partners, Ysios Capital, Innogest Capital, and Sabadell Venture Capital.